BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11911824)

  • 21. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice.
    Tan Sardjono C; Mottram PL; van de Velde NC; Powell MS; Power D; Slocombe RF; Wicks IP; Campbell IK; McKenzie SE; Brooks M; Stevenson AW; Hogarth PM
    Arthritis Rheum; 2005 Oct; 52(10):3220-9. PubMed ID: 16200626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal FcγRI mediates acute and chronic joint pain.
    Wang L; Jiang X; Zheng Q; Jeon SM; Chen T; Liu Y; Kulaga H; Reed R; Dong X; Caterina MJ; Qu L
    J Clin Invest; 2019 Jun; 129(9):3754-3769. PubMed ID: 31211699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
    Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
    Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation.
    Kim HY; Kim S; Chung DH
    J Clin Invest; 2006 Sep; 116(9):2484-92. PubMed ID: 16917543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression.
    Wallace PK; Keler T; Coleman K; Fisher J; Vitale L; Graziano RF; Guyre PM; Fanger MW
    J Leukoc Biol; 1997 Oct; 62(4):469-79. PubMed ID: 9335317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.
    Fossati-Jimack L; Ioan-Facsinay A; Reininger L; Chicheportiche Y; Watanabe N; Saito T; Hofhuis FM; Gessner JE; Schiller C; Schmidt RE; Honjo T; Verbeek JS; Izui S
    J Exp Med; 2000 Apr; 191(8):1293-302. PubMed ID: 10770797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of leukocyte immunoglobuin G receptors in vaccine-induced immunity to Streptococcus pneumoniae.
    Saeland E; Leusen JH; Vidarsson G; Kuis W; Sanders EA; Jonsdottir I; van de Winkel JG
    J Infect Dis; 2003 Jun; 187(11):1686-93. PubMed ID: 12751025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-function mutations in FcgammaRI of NOD mice: implications for the evolution of the Ig superfamily.
    Gavin AL; Tan PS; Hogarth PM
    EMBO J; 1998 Jul; 17(14):3850-7. PubMed ID: 9670002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci.
    Watson WC; Townes AS
    J Exp Med; 1985 Dec; 162(6):1878-91. PubMed ID: 3934318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes.
    van Montfoort N; de Jong JM; Schuurhuis DH; van der Voort EI; Camps MG; Huizinga TW; van Kooten C; Daha MR; Verbeek JS; Ossendorp F; Toes RE
    J Immunol; 2007 Jun; 178(12):7581-6. PubMed ID: 17548593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma.
    Bevaart L; Jansen MJ; van Vugt MJ; Verbeek JS; van de Winkel JG; Leusen JH
    Cancer Res; 2006 Feb; 66(3):1261-4. PubMed ID: 16452176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice.
    Keler T; Guyre PM; Vitale LA; Sundarapandiyan K; van De Winkel JG; Deo YM; Graziano RF
    J Immunol; 2000 Dec; 165(12):6738-42. PubMed ID: 11120792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models.
    Yılmaz Ç; Apak A; Özcengiz E; Özcengiz G
    Microbiol Immunol; 2016 Nov; 60(11):717-724. PubMed ID: 27761933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of murine fibrocyte differentiation by cross-linked IgG is dependent on FcγRI.
    Pilling D; Crawford JR; Verbeek JS; Gomer RH
    J Leukoc Biol; 2014 Aug; 96(2):275-82. PubMed ID: 24752483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG2a-mediated enhancement of antibody responses is dependent on FcRgamma+ bone marrow-derived cells.
    Diaz de Ståhl T; Heyman B
    Scand J Immunol; 2001 Nov; 54(5):495-500. PubMed ID: 11696201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells.
    Uciechowski P; Schwarz M; Gessner JE; Schmidt RE; Resch K; Radeke HH
    Eur J Immunol; 1998 Sep; 28(9):2928-35. PubMed ID: 9754580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo effector functions of high-affinity mouse IgG receptor FcγRI in disease and therapy models.
    Gillis CM; Zenatti PP; Mancardi DA; Beutier H; Fiette L; Macdonald LE; Murphy AJ; Celli S; Bousso P; Jönsson F; Bruhns P
    J Autoimmun; 2017 Jun; 80():95-102. PubMed ID: 27745779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IgG Fc receptor family.
    Gessner JE; Heiken H; Tamm A; Schmidt RE
    Ann Hematol; 1998 Jun; 76(6):231-48. PubMed ID: 9692811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-gamma-stimulated immune complex arthritis.
    van Lent PL; Nabbe KC; Blom AB; Sloetjes A; Holthuysen AE; Kolls J; Van De Loo FA; Holland SM; Van Den Berg WB
    Arthritis Res Ther; 2005; 7(4):R885-95. PubMed ID: 15987491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.